Top Trending Healthcare and Healthcare IT News: January 2021

Sunday 31 January 2021

Tumor Ablation Market Latest Technology, Top Companies, Trends and Growth Factors by 2023

Market Highlights:

Tumor ablation is a technique of removal of cancer tissue or cells of kidney, liver, bone, and soft tissue with invasive procedure. It is considered as excellent and convenient treatment option over other conventional surgical techniques. Factors that are propelling the growth of the tumor ablation market are surge in geriatric population, increase in prevalence of different types of cancer, rise in adoption of minimally invasive surgical procedures, increasing research and development in healthcare and advancement in technologies. According to the International Federation of Pharmaceutical Manufacturers & Associations, global pharmaceutical industry has spent more than USD 149.8 billion on pharmaceutical Research and development activities.

The cost containment policies by various governments, stringent regulatory environment for product approval, and scarcity of experts are likely to hinder market growth during the forecast period.

Regional Analysis:
The American market is expected to dominate the global tumor ablation market during the forecast period due to the increase in number of cancer cases along with growing geriatric population, adoption of advance technology in healthcare, and favorable reimbursement and regulatory authorities. The European market is expected to be the second-largest due to increased pool of cancer patients and rising healthcare expenditure. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing geriatric population in countries such as India and China, government initiatives and investment for the development of healthcare sector. The market in the Middle East & Africa is likely to account for the smallest share of the global tumor ablation market.

Segmentation:
The Global Tumor Ablation Market has been segmented on the basis of technology, treatment, application, and end-user.

The technology segment has been segregated into Radiofrequency, Microwave, Irreversible Electroporation, Cryoablation and others.

On the basis of treatment, the market has been classified as surgical, percutaneous and laparoscopic.

The tumor ablation market, by application, has been segmented into Liver cancer, Lung cancer, Breast cancer, Bone cancer, Prostate cancer and others.

End-user segment is divided into hospitals, surgical and ablation centers, and research institute.

Key Players:
Some of the key players in the global tumor ablation market are SonaCare Medical, Medtronic Plc., EDAP TMS, AngioDynamics Inc., Healthtronics Inc., Neuwave Medical, Inc., Boston Scientific Corporation, Biotronik, Galil Medical, Inc, Misonix Inc., and Covidien PL

Browse Complete Report @ https://www.marketresearchfuture.com/reports/tumor-ablation-market-7139

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Blog: https://healthcarenews12.blogspot.com/

Upcoming Trends, Growth Drivers, Application Analysis, Regional Outlook, Competitive Strategies and Forecast To 2023

Market Highlights

The growing acceptance of nasal splints accustomed by cosmetic advances is one of the major trends witnessed in the global nasal splint market over the forecast period. The ENT devices are becoming more advanced, efficient, and evolved in terms of technology. In case of people that are undergoing rhinoplasty might be affected with the after-effects such as a change in the shape of the nose owing to the movement of tissues and bones inside the nose. These problems are resolved with the use of external nasal splints that holds the structure and prevent any deformities, or other symptoms.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/7120

The nasal splints market is expected to witness tremendous growth owing to as increased adoption of nasal splints to prevent nasal deformities, bleeding, and inflammations to some extent, along with the rising acceptance of advanced procedures, and innovative surgical techniques. Other key factors such significant investments in R&D and expansions undertaken by key players are contributing towards the growth of the market. However, challenges such as need for skilled professionals, laborer, and economic sustainability are likely to curb the market growth during the forecast period.

Segmentation

The global nasal splints market is segmented into type, application, end-users. The nasal splints market, by type, the market is segmented into malleable nasal splints, airway nasal splints, and bivalve nasal splints. On the basis of application, the nasal splints market is bifurcated into plastic surgery, Rhinological operations, ENT-surgery, and others. On the basis of end-user, the market is segmented into hospitals & clinics, homecare, research centers, and others.

Regional Analysis

The Americas is the largest in the market owing to the increasing demand for aesthetic appearance and consistency among end-users in this region has enhancing the adoption of nasal splints in this region. The European region is the second largest nasal splints market over the forecast period due to high acceptance of nasal splints in research & development along with the increasing acquisition by the market players are also accountable for the growth of the nasal splints market.

The Asia Pacific region is likely to develop at the uppermost CAGR for the nasal splints market in the years to come. Moreover, the rising veterinary care services both at the veterinary hospital and at community level are expected to influence the market in a positive way. The Middle East and Africa accounts for the least market share due to low per capita income and lack of availability of well-trained healthcare professionals.

Key Players

Some of the key players in the global nasal splints market are Network Medical Products (UK), Summit Medical Group (US), Surgiform Technologies LLC (US), Mentor Worldwide LLC (US), DTR Medical (UK), Boston Medical Product Inc. (US), Medtronic plc (US), Olympus Corporation (Japan), Innovia Medical, LLC (US), Smith & Nephew (US), and others.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/nasal-splints-market-7120

Fabry diseases Market 2021- Trends and Global Size till 2023

Market Highlights:

The Global Fabry Disease Market is expected to grow at a CAGR of 6.8% during the forecast period. Technological advancements, strong pipeline, advancements in healthcare facilities, and favorable funding policies are expected to drive the market growth over the forecast period. Owing to the increasing awareness about Fabry disease, new and existing market players are coming up with better treatment approaches. For instance, in 2018, 2018, Amicus Therapeutics launched Galafold capsules 123mg for the treatment of patients aged 16 years and older with a confirmed diagnosis of Fabry disease and who have an amenable mutation.

However, diverse range of symptoms, and related complications can restrain the market growth over the assessment period.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/7064

Regional Analysis:

Geographically, the Americas is expected to dominate the global market owing to the increasing technological advancements and rising research and development activities. Gastrointestinal manifestations such as abdominal pain, diarrhea and nausea are significant burden in a patient with Fabry disease. So, for the advanced treatment of these patients SmartPill testing procedure is developed to gain additional understanding of Fabry disease manifestation via motility abnormalities in order to improve symptom targeted therapy. This device is currently under clinical trial and the sponsor of this study is Massachusetts General Hospital.

Europe is expected to hold the second largest market share. Nearly 2.2 in 10,000 people in the European Union (EU) are affected with Fabry disease and Fabrazyme (agalsidase beta), Galafold (migalastat) and Replagal (agalsidase alfa) are the three authorized drugs used for the treatment of Fabry disease.

Asia-Pacific is expected to be the fastest growing market owing to the improving healthcare infrastructure.

Moreover, the Middle East and Africa region is expected to hold the least market share in the global Fabry disease market.

Segmentation:

The Global Fabry Disease Market has been segmented into type, diagnosis & treatment and end user.

The market, on the basis of type, has been segmented into type-1 and type-2. The type-2 Fabry disease holds the major market share due to the high occurrence of type-2 Fabry disease i.e. 1 in 1,500 to 4000 males.

The market, by diagnosis & treatment, has been segmented into diagnosis and treatment. The diagnosis segment is further classified as blood test, urine test, thyroid test, lung function test, and imaging. The imaging segment includes electrocardiogram (EKG), echocardiogram, brain MRI, CT scan and others. The treatment segment is further classified as enzyme replacement therapy, gene therapy, pharmaceutical formulations containing agalsidase alfa, analgesics, anticonvulsants, nonsteroidal anti-inflammatory drugs (NSAIDs), and others.

The market, by end user, has been segmented into hospitals & clinics, diagnostic centers, research & academic institutes, and others.

Key Players:

Some of the prominent players in the global Fabry disease market are Amgen Inc., Amicus Therapeutics, Inc., AVROBIO, Inc., Idorsia Pharmaceuticals Ltd, Protalix, Bristol-Myers Squibb Company, GlaxoSmithKline, iBio, Inc., Neuraltus Pharmaceuticals, Inc., Novartis AG, Pfizer Inc., Sanofi, Shire, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd and others.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/fabry-disease-market-7064

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

Animal Genetics Market Dynamics, Future Growth, Regional Outlook, Key Insights and Global Industry Share By 2023

Market Highlights:

The Animal Genetics Market is expected to witness tremendous growth owing to as increased adoption of genetic services to prevent genetic diseases and business loss, and rising acceptance of advanced genetic technologies. Other key factors such significant investments in R&D and expansions undertaken by key players are contributing towards the growth of the market. However, challenges such as need for specific breeding programs for breeds with inferior economic performance, and economic sustainability in local breeds is likely to curb the market growth during the forecast period.
Get Free Sample!! https://www.marketresearchfuture.com/sample_request/7004
Segmentation:
The Global Animal Genetics Market is segmented into animal genetic products, services, and end-user. The Animal Genetics Market, by animal genetic products, the market is segmented into genetic materials and live animals. The live animals are further bifurcated into poultry, bovine, porcine, canine and others. The genetic materials are sub-segmented into semen and embryo. On the basis of services, the animal genetics market is bifurcated into genetic disease tests, DNA typing, gene trait tests, and others. On the basis of end-user, the market is segmented into veterinary hospitals & clinics, diagnostic centers, research centers and institutes, and others

Regional Analysis:
The Americas is the largest in the market owing to the high acceptance of animal genetics in research, the development in research expenditure along with the increasing acquisition by the market players are also accountable for the growth of the animal genetics market. For instance, in 2018, Neogen completed the acquisition of Livestock Genetic Services, a firm that specializes in genetic evaluations and data management for cattle-breeding organizations. This strategy enhances the company’s in-house genetic evaluation capabilities and further expands the company’s global network of animal genomics laboratories.

The European region is the second largest animal genetics market over the forecast period due to high consciousness about animal wellbeing coupled with increased expenditure on veterinary services in the region. As per a report by the European Pet Food Industry Federation, more than 75 million households in Europe own a pet.

The Asia Pacific region is likely to develop at the uppermost CAGR for the animal genetics market in the years to come. Moreover, the rising veterinary care services both at the veterinary hospital and at community level are expected to influence the market in a positive way.

The Middle East and Africa accounts for the least share due to low per capita income and lack of availability of well-trained healthcare professionals. However, there has been an increasing demand for test accuracy and consistency among end-users and the government in this region that is enhancing the adoption of animal genetic technology in this region.
Browse Complete Report @ https://www.marketresearchfuture.com/reports/animal-genetics-market-7004

Key Players:
Some of the key players in the global animal genetics market are Neogen Corporation (US), Genus (UK), URUS (US), EW Group (Germany), Groupe Grimaud (France), CRV Holding B.V. (The Netherland), Topigs Norsvin (Netherlands), Zoetis (US), Envigo (US) Hendrix Genetics BV (The Netherland), Animal Genetics (US), Alta Genetics (US), vetGen (US), and others.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Saturday 30 January 2021

Worldwide Trends on Microcarrier Market- Size, Share and research Report

Market Highlights:

The Global Microcarrier Market is anticipated to hold a market value of USD 1.18 billion with an estimated CAGR of 5.9% during the forecast period. A microcarrier is a support matrix allowing the growth of adherent cells. The microcarrier system provides high cell yields without having to resort to bulky equipment and tedious methodology. The rise in the use of microcarrier technology for various cell-based applications, coupled with the advantages of the microcarrier system such as its support for high yield of cells, facilitation of polarization and differentiation of cells, and lower risk of contamination are expected to drive the growth of the market during the forecast period. Moreover, the rapid growth of the biologics industry also fuels the growth of this market. On the other hand, strict regulatory framework, and limitation in production of high-density cell culture may hinder the growth of the market during the forecast period.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/6911

The global microcarrier market is currently dominated by many market players. These players are engaged in new product launches and strategic collaborations to strengthen its market position. For instance, in March 2018, Danaher announced that it has entered into a definitive agreement to acquire Integrated DNA Technologies, a privately-held provider of high-value consumables for genomics applications in next generation sequencing, synthetic biology, molecular biology, gene editing and molecular diagnostics.

Regional Analysis:

The market in the Americas is expected to dominate the global Microcarrier market during the forecast period owing to the increasing incidence of cancer and other chronic diseases, a well-developed healthcare sector and growing number of venture capital investments. According to data published by Centers for Disease Control and Prevention (CDC), 1,633,390 new cases of cancer were reported in the year 2015, and 595,919 people died of cancer in the United States in the same year. The European market is expected to be the second-largest due to government funding and support of the healthcare sector coupled with the strategic expansion of biopharmaceutical companies in this region. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the assessment period owing to growing disposable income and rising demand for cell-based vaccines. The market in the Middle East and Africa is likely to account for the smallest share of the global microcarrier market. The market growth in this region can be attributed to the growing government initiatives.

Segmentation:

The global microcarriers market has been segmented into product type, application, and end-user.The market, on the basis of type, has been segmented into equipment, and consumables.The market, based on equipment, has been segmented into bioreactors, culture vessels, cell counters, filtration systems, and other equipment.The market, based on consumables, has been sub-segmented into media, reagents, and microcarrier beads.The market, based on media, has been further segmented into serum-based media, serum-free media, and other media.

The market, based on microcarrier beads, has been sub-segmented into cationic microcarriers, collagen-coated microcarriers, protein-coated microcarriers, and other microcarrier beads.The market, on the basis of application, has been further segmented into vaccine manufacturing, cell therapy, biologics manufacturing, and other applications.The market, on the basis of end-user, has been further segmented into pharmaceutical and biotechnology companies, research institutes, and contract research organizations.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/microcarriers-market-6911

Key Players

Some of the key players in the global microcarrier market are Thermo Fisher Scientific Inc., Lonza, GENERAL ELECTRIC COMPANY, Corning Incorporated, Sartorius AG, Danaher, Merck KGaA, Becton, Dickinson and Company, Eppendorf AG and HiMedia Laboratories.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com .

3D Printing Medical Devices Market Industry Growth, Global Research, Future Demands Status, Emerging Trends and Global Forecast to 2023

Market Overview

3D printing functions an essential part of the medical and dental manufacturing sector and is the preferred choice of medical device manufacturers, for its cost-effective production of all types of medical devices such as the custom-made knee, hearing aids, hip implants, and prostheses.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/6830

Global 3D printing medical devices market is anticipated to grow due to influential factors such as the increase in investment by the growing use of 3D printing device in the healthcare industry the governments towards the healthcare sector, rising technological advancements in 3D printing, and easy production of medical devices.

According to a report issued by Market Research Future (MRFR), the global 3D printing medical devices market has been assessed to grow at a CAGR of 18% during the forecast period from 2018 to 2023.

Segmental Analysis

The global market for 3D printing medical devices has been segmented into types, component, technology, application, end-users, and regions.

Based on types, the global 3D printing medical device market has been segmented into prosthetics & implants, surgical guides, surgical instruments, and tissue engineering product. The surgical guide segment has been assessed to account for the largest market share in the type segment over the forecast period, due to its advantage of providing accurate implant restoration, resulting in a rise in the demand for the surgical guide has been increasing, and this is a crucial factor driving the growth of this market segment.

Based on the component, the market for 3D printing medical devices has been segmented into the 3D bioprinter, 3D printer, materials, software & services, and system. Software & services segment is projected to account for the largest market share in the component segment over the forecast period, due to the increase in advancements in the software solutions for manufacturing high-quality 3D-printed medical products.

On the basis of technology, the 3D printing medical device market has been segmented into 3D printing, droplet deposition, electron beam melting (EBM), laminated object manufacturing (LOM), laser beam melting, photopolymerization, poly-jet technology, and others. Photopolymerization segment has been assessed to account for the largest market share in the technology segment over the forecast period.

Based on application, the global market for 3d printing medical device has been segmented into clinical study devices, external wearable devices, implants, and tissue engineering. The external wearable devices segment assessed to account for the largest market share in the application segment over the forecast period.

By end-users, the market has been segmented into academic institutions, contract research organization, hospitals, medical and surgical centers, and pharma and biotech companies. The medical and surgical centers segment has been assessed to account for the largest market share in the end-user segment over the forecast period, due to the increase in the patient population and decrease in surgical and infection risks.

Based on the region, the market has been segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/3d-printing-medical-devices-market-6830

Key Players

The key players identified in the global 3D printing medical devices market are 3D Systems Corporations, 3T RPD Ltd., Arcam AB, Bio3D Technologies, EnvisionTEC, Cyfuse Medical K.K.EOS GmbHConcept, Laser GmbH, Materialise NV, Organovo Holdings, Inc., Oxford Performance Materials, Inc., Renishaw plc, Prodways Group, Stratasys Ltd., and SLM Solutions Group AG.

Regional Analysis

North America has been expected to dominate the global 3D printing medical device market over the forecast period, due to the growth in the demand for organ transplant surgeries in the region, and the increase in investments made by the government towards the research and development of advanced 3D printing technologies.

Europe is the second-largest regional market for 3D printing medical devices, owing to favorable government investments, rise in research and development. Additionally, the changing lifestyles of consumers have led to an increase in patient population and number of surgeries, consequently contributing to the growth of the 3D printing medical device market in the region.

Asia-Pacific has been assessed to grow as the fastest-growing region in the 3D printing device market through the forecast period, due to the growing prevalence of chronic diseases such as diabetes, blood pressure disorders among others, the increasing investments in the healthcare sector by the government, and increase in the geriatric population.

The Middle East & Africa region has been accounted for the comparatively smallest market share in the global 3D printing medical devices market owing to a healthcare sector that needs improvement, lack of medical knowledge, and inadequate medical facilities.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Urgent Care Apps Market Growth Factors, Developments Strategy, Historical Analysis, Covid 19 Impact on Industry and Regional Forecast 2023

- Market Research Future has published a half-cooked research report on the Global Urgent Care Apps Market.

The Global Urgent Care Apps Market continues on a gradual upward trajectory and is expected to cross USD 2595 Mn mark by the end of 2023. The global urgent care apps market stood at USD 314.2 Mn in 2017 and Market Research Future (MRFR) anticipates dynamite growth in the market with a CAGR over 42.20% over the forecast period which ends in 2023.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/6677

Urgent care apps are advantageous in managing medical conditions which need immediate attention. They act as an additional pathway for medical conditions which require prompt action but are non-life-threatening concerns. They offer an effective and low-cost option for the management of health conditions such as pregnancy, stroke, cardiac diseases, trauma, and others. Multiple use cases presented by urgent care apps are boosting the growth of the market. Also, these apps have been proven beneficial in post-hospital or post-operative care among patients.

The ubiquity of smartphones coupled with the growing penetration of 3G and 4G networks, especially in the emerging economies are contemplated to be reflecting positively on the growth of the global urgent care apps market. The digital revolution in healthcare is speeding up the adoption of urgent care apps and consequently fostering market growth.

The gradual shift in focus on personalized and patient-centric healthcare delivery has been a key driver for the growth of the global urgent care apps market. Urgent care apps deliver a diverse set of services with more flexible hours. They are particularly useful for elderly patients who require reassurance and offer them with access to immediate help during emergencies.

Raising awareness regarding the availability of medication management apps in combination with the factors mentioned above add fuel to the growth of the global urgent care apps market.

However, the market might be met by some challenges including the bulk of miscategorized apps in the App Store & Google Play and poor internet connectivity issues in underdeveloped regions which restrict the growth of the market.

Segmentation

The Global Urgent Care Apps Market has been segmented based on type and clinical area.

By type, the urgent care apps market has been segmented into emergency care triage apps, in-hospital communication & collaboration apps, and post-hospital apps. The post-hospital apps segment has been further segmented into medication management apps, care provider communication & collaboration apps, and rehabilitation apps.

By clinical area, the global urgent care apps market has been segmented into trauma, stroke, cardiac conditions, and others. The trauma segment is the largest segment on account of rising incidences of road accidents which necessitates trauma care and increasing awareness to address trauma by healthcare organizations. The cardiac conditions segment is expected to be the fastest growing segment owing to the gradual realization of the benefits of urgent care apps in the management of critical cardiac conditions.

Regional Analysis

The Americas, Europe, Asia Pacific, and the Middle East & Africa are the key markets for urgent care apps.

North America is a significant market for urgent care apps, led by North America. Deep penetration of smartphones and 3G and 4G networks along with escalating healthcare cost and constant need to address the same are augmenting the market in North America. Moreover, the region tends to quickly adapt to emerging technologies which further supports the growth of the urgent care apps market. Other driving factors include raising awareness and increasing focus on personalized healthcare.

Europe's market growth can be exclusively attributed to increasing initiatives by the government towards the promotion of such apps and towering need to curtail healthcare costs. Germany, Italy, France, Spain, and the UK are the major markets in Europe.

Asia Pacific market for urgent care apps is anticipated to have an expeditious growth in the coming years. Growing penetration of smartphones in the emerging economies of Asia Pacific coupled with raising awareness about healthcare management apps can be accredited for the growth of the urgent care apps market in Asia Pacific.

Access Report Details @ https://www.marketresearchfuture.com/reports/urgent-care-apps-market-6677

Competitive Landscape

Some of the prominent players operating in the global urgent care apps market include Forward Health, Pivot Design Group, Johnson & Johnson, Twiage, Siilo, Alayacare, PatientSafe Solutions, Vocera Communications, Hospify, Argusoft, Voalte, Pulsara, Imprivata, Allm, and TigerConnect.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Friday 29 January 2021

Healthcare Cloud Computing Market 2018 In-Depth Analysis of Industry Share, Size, Growth Outlook up to 2023

Market Insights

Cloud computing offers several important benefits which have significantly impacted the general market for cloud-based technologies. The various features of the cloud deployment of IT software increase the collection of data in real-time and significantly improves data retrieval among other things. Market Research Future has deeply examined the global healthcare cloud computing market to understand the various factors that influence growth in its upcoming report on the subject. Document processing is an ongoing task in healthcare facilities and the speed and efficiency that cloud computing offers has increased the adoption of the same.

Cloud computing reduces overall costs as it is used without the need for physical infrastructure. The internet is used to store and manage data which also cuts down on maintenance costs. This is a significant driver of the global healthcare cloud computing market. The IT revolution and widespread growth of and demand for cloud computing has affected the healthcare sector in a highly positive manner. The large amounts of data generated in healthcare has encouraged the adoption of cloud computing. The generation of large volumes of data has increased further with high adoption of Scalability and flexibility are some of the growth driving factors in the global healthcare cloud computing market. Major healthcare cloud computing players are actively involved in the development of new and improved services which will continue to optimize operations in large and complex industries such as healthcare. Security risks and the concern regarding sensitive data being made available on the cloud is expected to restrain market growth. Cloud breaches with regards to data and inefficient backup activities undertaken by healthcare organizations are likely to pose challenges to market growth, which may be addressed to some extent in the coming years.

Access Report @ https://www.marketresearchfuture.com/reports/healthcare-cloud-computing-market-6519

Market Segmentation

The global healthcare cloud computing market is segmented in MRFR's report on the basis of applications, deployment, service, end-user, and region. Healthcare cloud computing has two key applications, namely Non -Clinical Information System (NCIS), and Clinical Information System (CIS). The CIS segment is further sub-segmented to include electronic health records (EHR), pharmacy information system (PIS), computerized physician order entry system (CPOE), and others.

Deployment of healthcare cloud computing segmented into private cloud, public cloud, and hybrid cloud. Healthcare cloud computing makes its possible to offer services in various innovative forms which include Software-As-A-Service, Infrastructure-As-A-Service, and Platform-As-A-Service. Healthcare providers and healthcare players make up the end-users of healthcare cloud computing .

The global healthcare cloud computing market is segmented by region into Europe, Latin America, North America, the Asia Pacific and the Middle East and Africa.

Regional Analysis

North America due to its inclusion of the U.S where there is a high concentration of market players and the presence of a significant healthcare sector is expected to be a significant market in the global healthcare cloud computing market. North America has a well-established healthcare sector due to the concentration of developed economies in the region. The region also displays an affinity for the adoption of advanced technology.

The Asia Pacific is a rapidly growing market due to the presence of a rapidly developing healthcare sector in the region. Countries such as India and China are among the most populous countries in the world which have a massive patient population. The need to have efficient operations in treating these masses is expected to encourage the adoption of advanced healthcare cloud computing solutions during the forecast period.

Key Players

Eminent market players that have been included in MRFR’s analysis of the competitive landscape include GE Healthcare, Athena Health Inc., IBM Corporation, Sectra AB, CareCloud Corporation, Carestream Corporation, Agfa-Gevaert N.V., NextGen Healthcare, ClearData Networks Inc., Nuance Communications, Oracle Corporation, Siemens Healthineers, Microsoft Corporation, Cerner Corporation, Merge Healthcare Inc., and Dell Inc.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Thursday 28 January 2021

Appendiceal Cancer Treatment Market 2021 | Latest Innovations, COVID-19 Impact , Revenue, Price and Gross Margin Study with Forecast to 2023

Market Highlights

The appendix is a part of the digestive system and is located close to where the large intestine and small intestine comes together. Previously thought to be a vestigial (or non-functional) organ, the appendix is now known as a source of healthy bacteria and vital immune cells necessary for normal functioning of the body. The rise in targeted and innovative therapies confined to appendiceal cancer and increased awareness about the severity of the disease are supposed to increase market growth.

Additionally, the favorable reimbursement scenario and rising healthcare expenditure are likely to boost the market growth. On the other hand, growing preference for alternative drug delivery modes such as nasal sprays, high-cost associated with appendiceal cancer treatment, and stringent government regulations for product approval may hamper the growth of the market during the forecast period.

The global appendiceal cancer treatment market is currently dominated by many market players. The key players in the market are engaged in new product launches and strategic collaborations to strengthen their market position. For instance, in January 2016, Merck acquired IOmet Pharma Ltd., UK based drug discovery company focused on the field of cancer immunotherapy and cancer metabolism.

Regional Analysis

The market in the Americas is expected to dominate the global appendiceal cancer treatment market during the forecast period owing to the favorable reimbursement scenario and focus of the government on growing number of rare cancers. According to the American Cancer Society, it affects less than 1000 people each year and accounts for about five percent of all gastrointestinal cancers in the US. The European market is projected to be the second-largest due to government funding and support of the healthcare sector. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the assessment period owing to growing disposable income, and favorable government initiatives for healthcare facilities. The market in the Middle East & Africa is likely to account for the smallest share of the global appendiceal cancer treatment market. The market growth in this region can be attributed to the lack of healthcare infrastructure.

Access Report @ https://www.marketresearchfuture.com/reports/appendiceal-cancer-treatment-market-6504

Segmentation

The global appendiceal cancer treatment market has been segmented into type, treatment, and end-user.

The market, on the basis of type, has been segmented into neuroendocrine tumors and carcinomas.

The market, based on carcinomas, has been sub-segmented into mucinous adenocarcinoma, goblet cell carcinoids, intestinal-type adenocarcinoma, signet-ring cell adenocarcinoma, and paraganglioma. Mucinous cystadenocarcinoma is the most common form among carcinomas and affects about 20 percent of all the carcinoma cases. As a result, this type of carcinoma is projected to contribute a large share in the global appendiceal cancer treatment market. On the other hand, goblet cell carcinoids tumors have found to be the most prevalent type of carcinomas after mucinous cystadenocarcinoma, and a number of companies are involved in the development of novel therapeutic approaches for its treatment which has led to the rapid growth of this segment.

The market, by treatment, has been segmented into surgery, chemotherapy and radiation therapy.

The market, based on surgery, has been further segmented into appendectomy, hemicolectomy, and cytoreduction.

The market, based on chemotherapy, has been sub-segmented into hyperthermic intraperitoneal chemotherapy and systemic chemotherapy.

The market, by end-user, has been segmented into hospitals and clinics, cancer research institutes, and others.

Key Players

Some of the key players in the global appendiceal cancer treatment market are Pfizer Inc., Eli Lilly & Company, AbbVie, Inc., Bristol-Myers Squibb Company, F. Hoffman-La Roche Ltd., Becton, Dickinson & Company, Novartis AG, General Electric Company, AstraZeneca, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Sanofi, Bayer AG, Amgen Inc. and Merck.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Augmented Reality in Healthcare Market 2020: Business Trends, COVID – 19 Outbreak, Competitor Strategy, Global Segments, Industry Profit Growth, Landscape and Demand

Market Highlights

The global augmented reality in the healthcare market is spanned across Americas, Europe, Asia Pacific, and Rest of world. North America dominates the augmented reality in healthcare market due to growing adoption of artificial reality and internet of things, which is propelling the market growth in this region to a large extent. On January 12, 2017, Philips announced its new and innovative augmented-reality in surgical navigation technology, designed for the image-guided spine, cranial and trauma surgery. This augmented-reality is the combination of 3D X-ray imaging, optical imaging, and others.

The North American region is experiencing a higher demand due to growing adoption of augmented reality technology and the increasing need to reduce the healthcare cost in this region is propelling the growth of this market to a large extent. The prominent companies such Augmedix (U.S.), Oculus VR (U.S.), CAE Healthcare (U.S.), Philips Healthcare (Netherlands & U.S.), 3D Systems (U.S.), are providing augmented reality in healthcare solutions in the market. These major players are investing in offering augmented reality in healthcare solution across the world.

The global augmented reality in the healthcare market is expected to reach USD ~ 1.32 billion at a CAGR of over 23% by the end of the forecast period.

Taste the market data and market information presented through more than 30 market data tables and figures spread over 100 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “The Global Augmented reality in healthcare Market Research Report -Forecast to 2023”.

ACCESS REPORT DETAILS @ https://www.marketresearchfuture.com/reports/augmented-reality-in-healthcare-market-5236

Global Augmented Reality in Healthcare Market Segmentation

The global augmented reality in the healthcare market is segmented into component, device type, application, and region. The component is further segmented into hardware, software, and others. Further, the hardware segment is sub-segmented into sensors, displays and projectors, position tracker, cameras, and others. The device type segment is sub-segmented into head-mounted display, handheld device, and others. The application segment is further sub-segmented into fitness management, medical training and education and others. The market is spanned across regions including North America, Europe, Asia Pacific, and rest of the world.

The prominent players in the global augmented reality in healthcare market are Google LLC. (U.S.), Microsoft Corporation (U.S.), DAQRI (U.S.), Mindmaze (Switzerland), Wikitude GmbH (Austria), Medical Realities (U.K), Atheer (U.S.), Augmedix (U.S.), Oculus VR (U.S.), CAE Healthcare (U.S.), Philips Healthcare (Netherlands & U.S.), 3D Systems (U.S.), Blippar (U.K), VirtaMed (Switzerland), HTC (Taiwan), Siemens Healthineers (Germany), Magic Leap, Inc. (U.S.), and Osterhout Design Group (U.S.) and Virtually Better (U.S.), among others.

Market Research Analysis:

The global augmented reality in healthcare market consists of the Americas, Europe, Asia Pacific, and Rest of world. North America is dominating the global augmented reality in the healthcare market. The augmented reality in the healthcare market is witnessing a high growth due to increasing demand for medical services via which the patients are being treated, propelling the market growth of augmented reality in healthcare in this region. Europe is projected to hold the second largest share of the augmented reality in healthcare market during the forecast period as the sensors are widely used in healthcare. For instance, multi-sensory learning is being considered to be very beneficial in transmitting information in medical sector. Asia Pacific is expected to witness the highest CAGR in the coming years.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.